Don't wanna be here? Send us removal request.
Statistics
We looked inside some of the posts by sumitchoudhari-blog and here's what we found interesting.
Average Info
Notes Per Post
0
Likes Per Post
0
Reblog Per Post
0
Reply Per Post
0
Time Between Posts
2 days
Number of Posts By Type
Text
17
Last Seen Tumblr Blogs
Fun Fact
Tumblr is used by 21% of adults online aged 18-29 years.
Text
Healthcare Analytics Market Revenue at CAGR of ~27.1% Forecasts by 2024
Healthcare analytics offers the macro and micro level insights into hospital management, patient records, costs, diagnoses, and more in the burgeoning healthcare industry. Real-time information provided by healthcare analytics, help managers to make decisions, deliver actionable insights, and thus to operate in a better fashion.
Healthcare analytics is revolutionizing pharmaceutical organizations as well. Using more data and analytics, pharmaceutical organizations can assure their formulations positively. As a result, the uptake of healthcare analytics solutions is widening rapidly, leading to an increase in the size of its market.
Moreover, the latest trend of increasing collaboration between healthcare organizations and pharmaceutical companies to improve treatment plans is escalating the market on the global platform, revolutionizing the healthcare sector, completely.
Considering the exponential traction that the market is garnering currently, Market Research Future (MRFR) in its recently published study analysis asserts that the global healthcare analytics is poised to demonstrate significant growth registering a staggering double-digit CAGR of 27.1% throughout the forecast period (2019-2024). In the year 2018, the market had valued at USD 12,126.70 MN.
The demand to curtail healthcare costs is playing a vital role in the overall growth of the market. Additional factors that are bolstering the growth of the market include the high adoption of technological advancements in the field of healthcare and the availability of low-cost technology that improves patient care by improving existing procedures, providing better services.
Key Players
Key players leading the global healthcare analytics market include
Cerner
SAS Institute Inc.
Allscripts Healthcare Solutions
IBM
Inovalon
Wipro
Cotiviti
Health Catalyst
Citiustech
Mckesson
Oracle
Optum
SCIO Health Analytics
Medeanalytics
Vitreoshealth
Segmentation
For a better understanding, the report has been segmented into six key dynamics: -
By Type : Descriptive Analytics, Prescriptive Analytics, Predictive Analytics, and Cognitive Analytics.
By Component : Software and Services.
By Delivery Model : On-premise and On-demand.
By Application : Financial Analytics (Claims Processing, Payment Integrity & Fraud, Revenue Cycle Management (RCM), Waste & Abuse (FWA), Risk Adjustment & Assessment), Clinical Analytics (Quality Improvement & Clinical Benchmarking, Clinical Decision Support (CDS)), Operational & Administrative Analytics, and Population Health Analytics among others.
By End-user : Payers (Private Insurance Companies, Employers and Private Exchanges, Government Agencies,) and Providers (Hospitals & Clinics, Post-Acute Care Organizations, Ambulatory Settings), among others.
By Regions : Europe, North America, Asia Pacific, and the Rest-of-the-World.
Regional Market Summary
North America, heading with the presence of major players, accounts for the leading region in the global healthcare analytics market. Rapid technological advancements in RCM and clinical analytics and increasing adoption of healthcare IT drive the regional market. Additional factors that are bolstering growth in the regional market include the rising government initiatives to reduce medical errors and the use of big data and mHealth solutions. Also, increased focus on big data management & analysis, the establishment of healthcare policies by the federal government, and early emergence and adoption of healthcare analytics across the region would fuel the growth of the market during the forecast period.
The healthcare analytics market in the European region accounts for the second-largest market, globally. Factors such as government support and the presence of a well-established healthcare sector foster market growth in the region. Moreover, the increasing number of healthcare infrastructures and the healthcare insurance companies are fueling the increase in the regional market.
The Asia Pacific healthcare analytics market is emerging as a profitable market globally. Factors such as vast technological advancements and the increasing demand to reduce medical errors are propelling the growth in the regional healthcare analytics market. With the several niche market players trying to leverage the share in the regional market, the number of technology providers is also expected to increase over the forecast period.
Moreover, factors such as the increasing patient pool drive the growth of the regional market, creating a huge demand for healthcare analytics in the region. The market is majorly propelled by some of the rapidly developing countries such as India and China.
Browse Complete Research Report @
https://www.marketresearchfuture.com/reports/healthcare-analytics-market-7819
Table Of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Typology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
TOC Continued….
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Hepatitis B Treatment Market Size at High Volume Predicted to Reach by 2024; Assert MRFR
The global Hepatitis B Treatment Market is expected to grow at an approximate CAGR of 5.3% during the forecast period, 2018–2024.
Hepatitis B is a viral infection caused by a hepatitis B virus. This infection lasts for a longer period and can cause many other complications, such as scarring in the liver, liver cancer or liver failure. The person suffering from hepatitis B faces various symptoms such as fever, fatigue, nausea, and muscle aches. The other symptoms include jaundice, swelling in the legs, poor appetite, drowsiness and many more. The key factors contributing the market growth are growing geriatric population, increasing the prevalence of viral infection and growing sexually transmitted diseases among the population contribute to driving the market growth. The World Hepatitis Alliance (WHA), 2017 reported that 52 million children across the world are living with viral hepatitis. Such a huge population suffering from Hepatitis boosts the market growth.
However, the factor such as the side effects or complication caused due to treatment may hamper the market growth.
Global Hepatitis B Treatment Market: Competitive Landscape
Some of the key players in the global Hepatitis B Treatment Market are
Accord Healthcare Inc.
Apotex Corp.
Arbutus Biopharma
Arrowhead Pharma
Aurobindo Pharma Limited
Bristol-Myers Squibb Company
Gilead Sciences, Inc.
GlaxoSmithKline
Lupin Pharmaceuticals, Inc.
Merck & Co., Inc.
Par Pharmaceutical, Inc.
Teva Pharmaceuticals
Zydus Pharmaceuticals
Hepatitis B Treatment Market Segmentation
The global Hepatitis B Treatment Market is segmented on the basis of type, treatment, distribution channel, and region.
Based on type, the market is segmented into acute and chronic. On the basis of treatment, the global Hepatitis B Treatment Market is segmented into immune modulator drugs, antiviral drugs, vaccine, and surgery (liver transplant). The immune modulator drugs are further sub-segmented into pegylated interferon and interferon alpha. The antiviral drugs are sub-segmented into tenofovir disoproxil, entecavir, telbivudine, lamivudine, and others. By distribution channel, the market is segmented into hospital & retail pharmacies and online pharmacies.
Hepatitis B Treatment Market Regional Analysis
The Americas dominates the global market for Hepatitis B Treatment Market. Factors such as the presence of a large number of healthcare companies, increasing geriatric population and high healthcare expenditure among the population within the Americas drives the market. The National Vaccine Information Center reported 3,370 cases of hepatitis B were reported in the US in 2015.
Following similar trends, Europe stood second in the global Hepatitis B Treatment Market market. The increased prevalence of viral diseases and growing healthcare expenditure in this region boost market growth. Also, the presence of developed economies, increasing healthcare facilities, and rising government funding for healthcare boost market growth. Asia Pacific was the fastest growing region for the global Hepatitis B Treatment Marketin 2017. This can be attributed due to the increasing incidences of HIV infection and rising demand for the treatment of viral infection among the population boosts market growth.
On the other hand, the Middle East and Africa holds the least share in the global Hepatitis B Treatment Market market. The poor economies within the African region and lack of awareness about the treatment methods hinder the market growth.
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Treatment Trends & Assessment
TOC Continued….!
Browse Complete Report Details @
https://www.marketresearchfuture.com/reports/hepatitis-b-treatment-market-7817
About US:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Soft Tissue Repair Market by Technology & End-User - 2023 | Market Research Future
The Global Soft Tissue Repair Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 5200 million in 2017 and is projected to register a CAGR of 6.2% over the forecast period.
The rising cases of sports-related injuries and technological advancements are some of the key factors driving the soft tissue repair market. For instance, in 2016, Colorado Therapeutics received FDA approval for its xenograft implant. The xenograft implant is designed for the surgical repair of damaged or ruptured membranes.
Various other factors such as increasing awareness about orthopedic disorders and other related conditions, improvement in reimbursement policies, untapped emerging markets, and increasing healthcare expenditure are also expected to propel the growth of the market.
However, the high cost of advanced equipment and a shortage of physicians in emerging markets can hamper market growth over the forecast period.
Segmentation
The global soft tissue repair market is segmented based on product, application, end user, and region.
the global market for soft tissue repair, by product, is segmented into fixation products, tissue patch/match, laparoscopic instrument, and others. The fixation products segment is further classified as a suture, suture anchors, and interference screw. The tissue patch/match segment is further classified as biological, and synthetic. The biological segment includes allograft and xenograft.
Based on application, the market is segmented into orthopedic surgery, skin repair, hernia repair, vaginal sling repair, dental reconstruction, cardiovascular surgery, breast reconstruction, and others.
Based on end user, the market is segmented into hospitals, clinics, research & academic institutes, and others.
In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.
The soft tissue repair market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European soft tissue repair market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The soft tissue repair market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The soft tissue repair market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
The Americas dominated the global market for soft tissue repair owing to the increasing healthcare expenditure presence of major market players and rising geriatric population within the region. As per the data suggested by the United Census Bureau, by 2060, the US is projected to grow by 79 million people, from about 326 million today to 404 million. The population is projected to cross the 400-million threshold in 2058.
In 2017, it was estimated that Europe stood second in the global soft tissue repair market. Robust research and development (R&D) sector along with the availability of funding opportunities in research and innovation will support the market growth.
Asia-Pacific (APAC) is expected to represent the phenomenal market growth throughout the forecast period due to increasing demand for medical technology, growing health awareness, and growing aging population coupled with the rising prevalence of orthopedic diseases in India, Japan, and Australia. For instance, according to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), in 2016, around 12.4% of the population in the region was 60 years or older and is projected to reach to more than 1.3 billion by 2050.
On the other hand, the Middle East and Africa held the least share in the global soft tissue repair market due to the low economic development, especially within the African region.
Key Players
Some of the key players in the global soft tissue repair market are Stryker Corporation, C.R. Bard, Inc., Arthrex, Inc., Integra LifeScience Corporation, Depuy Synthes, Smith & Nephew plc, Allergan Plc., Athersys, Inc., CryoLife, Inc., Medtronic Plc., Organogenesis Inc., Zimmer Biomet Holdings, Inc., Lifenet Health, Inc., American Medical Systems Inc., U.S. Stem Cell, Inc., Wright Medical Group, Inc., Isto Biologics, and others.
Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/soft-tissue-repair-market-7810
Detailed Table Of Contents
1 Report Prologue
2 Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
5 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5 Market Factor analysis
5.1 Porter’s Five Force Analysis
5.1.1 Bargaining Power Of Buyer
5.1.2 Bargaining Power Of Supplier
5.1.3 Threat From Substitute
5.1.4 Threat From A New Entrant
5.1.5 Intensity Of Competitive Rivalry
TOC Continued…
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Clinical Trials Market by Technology & End-User - 2023 | Market Research Future
Clinical Trials Market - Highlights
Clinical trial is a research study which involve people (healthy volunteers or patients) to test the safety and efficacy of a new treatment or medicine. In healthcare industry clinical trials are performed for medicine, medical devices which includes hearing aid and surgical procedure.
The key factors driving the clinical trial industry includes rising prevalence of diseases, high R&D expenditure of the pharmaceutical industry, and growth of new treatments such as personalized medicine is supporting to grow the market. However, factors such as lack of skilled workforce clinical research, lower healthcare reimbursement in the developing countries and stringent regulations for patient enrollment, hinder the market growth.
The market for global clinical trial market is estimated to grow at an approximate CAGR of 5.7% from 2017 to 2023
However, factors such as lack of skilled workforce clinical research, lower healthcare reimbursement in the developing countries and stringent regulations for patient enrollment, hinder the market growth.
Key Players:
Charles River Laboratories, Paraxel International Corporation, Quintiles IMS, ICON plc, SGS SA, Eli Lilly and Company, Novo Nordisk A/S, Clinipace, Laboratory Corporation of America, Pfizer and Others are some of the major players for global clinical trials market.
Segmentation:
The global clinical trials market is segmented on the basis of phase, study design, indication and end users. On the basis of the phase, the market is categorized into phase I, phase II, phase III, and phase IV. On the basis of study design, the global clinical trials market is segmented into interventional, observational and expanded access. On the basis of indication, the global clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, central nervous system (CNS) condition, diabetes, obesity, cardiovascular and others. On the basis of the end-user, the market is segmented into dental hospitals & clinics, dental institutes and dental academic and research institutes.
On the regional basis, the global clinical trial market in the Americas is segmented into two major regions, i.e., North America and Latin America. The North American region is likely to hold the major share in the global clinical trial market owing to the presence of well-established healthcare sector, growing prevalence of high diseases and also increasing funding from government. Additionally, the Asia-Pacific region is anticipated to be the fastest growing region due to increasing geriatric population with either one or more disease and favorable environment such as low operating cost, skilled technician and increasing healthcare facilities provides favorable scenario for the market growth.
Regional Analysis:
The Americas dominate the global clinical trial market owing to the presence of major pharmaceutical and biotech companies with R&D units in America and increasing patient population suffering from cardiac problem boost the clinical trial market in this region. Moreover, rising healthcare expenditure and presence of developed economies like U.S. and Canada fuels the market growth.
Europe is second in the global clinical trial market owing to increasing government support, rising clinical trail facilities both in private and government sector increases the clinical trial market in Europe.
Asia-Pacific region is the fastest growing market owing to the presence of developing economies, a growing healthcare sector and standard regulations related to healthcare industry promotes the manufactures to establish R&D unit in this region which drives the market with the region. The Middle East & Africa has the least share in the global clinical trial market owing to the presence of poor economies and stringent government policies, especially in the African region.
Browse Complete 110 Pages Premium Research Report Enabled With Respective Tables And Figures At https://www.marketresearchfuture.com/reports/clinical-trials-market-7787
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
TOC Continued...!
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Aortic Aneurysm Market by 2023 – Concerns over the Rising Healthcare Costs Propel Industry to a high CAGR!
The global aortic aneurysm market held a market value of USD 2,357.6 million in 2017 and is projected to grow at a CAGR of 8.4% over the forecast period. An aortic aneurysm is an abnormal enlargement or bulging of the wall of the aorta. Aortic aneurysm has two types such as an abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). An abdominal aortic aneurysm is an aneurysm in the part of the aorta that passes through the abdomen while thoracic aortic aneurysm is an aortic aneurysm that presents mainly in the thorax.
Some of the market growth factors include rising prevalence of tobacco smoking in the developed and developing countries, worldwide growing elderly population coupled with the increasing burden of cardiovascular diseases, favorable reimbursement scenarios for surgical treatment of aortic aneurysms, and mounting technological advancements in products. In contrast, the presence of low reimbursement rates in the developing countries and higher cost of aortic aneurysm treatment and devices are anticipated to hinder the market growth during the next five years.
Segmentation
The global aortic aneurysm market has been segmented into type, product, treatment, end user, and region.
By type, the market has been segmented into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA).
On the basis of product, the market has been divided into stent-grafts, catheters, and others.
By treatment, the market has been classified into endovascular aneurysm repair (EVAR) and open surgical repair (OSR).
Based on end user, the market has been categorized into hospitals and clinics, ambulatory surgery centers (ASCs), and others.
Key Players
Some of the spearheading players in the global aortic aneurysm market are
Medtronic plc
Cook Medical
Terumo Medical Corporation
Microport Scientific Corporation
MAQUET Holding B.V. & Co. KG
Endologix Inc.
L. Gore & Associates
Lombard Medical Limited
JO0TEC AG (CryoLife Inc.)
and Cardinal Health Inc.
Regional Analysis
The global aortic aneurysm market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas would continue its supremacy over the forecast period attributed to the presence of sophisticated medical and healthcare infrastructure and major market participants, higher spending on the healthcare, and frequent launches of novel devices in the US and Canada. For instance, in 2015, Cook Group Incorporated launched its Zenith Alpha abdominal endovascular graft in Canada.
Europe would be the second-largest value contributor in the aortic aneurysm market due to the highest prevalence of tobacco smoking and the presence of favorable initiatives by several organizations to reduce the burden of aortic aneurysm. For instance, the World Health Organization (WHO) stated that presently, Europe has the highest prevalence of tobacco smoking among adults (28%) and some of the highest prevalence of tobacco use by adolescents.
Browse Complete 100 Pages Premium Research Report Enabled with 82 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/aortic-aneurysm-market-7776
Asia-Pacific is likely to witness the fastest market growth during the forecast period due to growth in increasing geriatric population and prevalence of cardiovascular diseases & hypertension, and growing awareness about aortic aneurysm treatment, and developing healthcare infrastructure in India, China, and Australia. For instance, WHO reported that one million people in the World Health Organization Western Pacific Region die each year from cardiovascular disease caused by tobacco use and more than 1 in 5 cardiovascular diseases, such as heart attack and stroke, result from smoking?
The Middle East & Africa has the least share of the global aortic aneurysm market. In addition, the major market share of the region would be held by the Middle Eastern region. Several studies reported that aortic aneurysm is very rare in the Middle East and very few lives are threatened by deadly aortic aneurysms annually in the Middle East region.
Table Of Contents
Chapter 1 Report Prologue
Chapter 2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Detection Technique Trends & Assessment
TOC Continued…
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Medical Terminology Software Market Research, Global Analysis, Industry Demand and Forecast 2023
It is estimated that the global medical terminology software market is expected to register a CAGR ~20% during the forecast period of 2018–2023.
Medical terminology software industry will witness a strong growth it is beneficial in enhancing the efficiency of a laboratory by providing operators with increased inventory control and tracking, including greater flexibility to address changing needs of the laboratory and business conditions.
The rising focus on minimizing medical errors, government initiatives for HCIT adoption, and disparity and fragmentation in the terminology content of healthcare organizations are anticipated to fuel the growth of the market. On the other hand, the restricted access to systems in emerging countries is expected to hamper the growth of the market.
Segmentation:
The global medical terminology software market is segmented on the basis of product & service, application, and end user.
The medical terminology software market, by product & service, is categorized into services and platforms.
Based on application, the medical terminology software market is segmented into data aggregation, reimbursement, public health surveillance, data integration, decision support, clinical trials, quality reporting, and clinical guidelines.
On the basis of end user, the market is segmented into healthcare providers, healthcare payers, and healthcare IT vendors. The healthcare providers subcategory is further divided into healthcare service providers and health information exchanges. The healthcare payer’s subcategory is further divided into private payers and public payers
Key Players:
Some of the key players in the global medical terminology software market are
Wolters Kluwer
3M
Intelligent Medical Objects
Apelon
Clinical Architecture
CareCom
Bitac
B2i Healthcare
BT Clinical Computing
and HiveWorx
Medical Terminology Software Market: Highlights
It is estimated that the global medical terminology software market is expected to register a CAGR ~20% during the forecast period of 2018–2023.
Medical terminology software industry will witness a strong growth it is beneficial in enhancing the efficiency of a laboratory by providing operators with increased inventory control and tracking, including greater flexibility to address changing needs of the laboratory and business conditions.
The rising focus on minimizing medical errors, government initiatives for HCIT adoption, and disparity and fragmentation in the terminology content of healthcare organizations are anticipated to fuel the growth of the market. On the other hand, the restricted access to systems in emerging countries is expected to hamper the growth of the market.
The global medical terminology software market is conquered by several players. The key players are involved in new product launches, as well as strategic collaborations to brace their position in the market. For instance, in 2016, Wolters Kluwer (Netherlands) announced a partnership with HealthCore, Inc., (US), a clinical outcomes research subsidiary of Anthem, Inc. (US), to provide data normalization services to the California Integrated Data Exchange through its health language enterprise terminology management platform. This initiative is anticipated to open new avenues for the firm to cater to the untapped markets in this region.
Browse Complete 160 Pages Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/medical-terminology-software-market-7785
Regional Analysis:
The Americas is expected to hold a major share in the global medical terminology software market can be attributed to the growing demand for accurate data exchange between healthcare providers and payers to streamline workflows in the region.
Europe is expected to hold the second largest share in the medical terminology software market due to the increasing need to maintain data integrity is expected to provide further growth opportunities for market players in the coming years.
Asia-Pacific was projected to be the fastest growing region for the global medical terminology software market due to the high adoption of HCIT technologies, regulatory requirements regarding patient safety. The Middle East and Africa holds the least share in the market due to fewer initiatives taken by the government.
Table Of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Overview
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
TOC Continued…
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Dental Industry Market Industry Booming Demand by Top Regions and Major Segments Till 2023
The dental industry includes the diagnosis, treatment, instruments, and devices related to oral health. There are various problems related to oral health such as pigmentation in gums, teeth cavity, brown or discoloration of teeth and others which are treated under the dental, medical industry. The key factors driving the dental industry include rising aging population globally, growing demand for cosmetic dentistry treatments, and increasing demand for dental procedures.
However, factors such as low dental insurance coverage compared to general health, lack of technological awareness and grey market of dental products, hinder the market growth. The market for the global dental industry is estimated to grow at an approximate CAGR of 7.6% from 2018 to 2023.
Global Dental Industry Market: Competitive Landscape
Some of the key players in the global Dental Industry Market are
Henry Schein Inc.
Hu-Friedy Mfg Co.
Ivoclar Vivadent AG
Nakanishi Inc., Patterson Companies Inc.
Dentsply Sirona
Ultradent Products Inc.
Young Innovations Inc.
3M Company
Zimmer Biomet
Kangda Medical
Dental Industry Market Segmentation
The global dental industry market is segmented on the basis of discipline, consumables and end users. On the basis of the discipline, the market is categorized into restorative dentistry, endodontics, prosthodontics, orthodontics, periodontics, and oral surgery.
On the basis of consumables, the global dental industry market is segmented into dental burs, whitening material, dental biomaterial, gingival retraction material, dental anesthetic, dental syringe, and endodontic supplies. The dental biomaterial segment is sub-segmented into dental cement, dental bone graft and regenerative tissue material. The gingival retraction material is further sub-segmented into gingival hemostatic agents, gingival retraction cord and gingival retraction paste/gels/cap. The dental anesthetic is further sub-segmented into topical anesthetics, injectable anesthetic, and non-injectable anesthetic. The dental syringe is sub-segmented into a non-disposable syringe and disposable syringes/ safety syringes. The endodontic supplies are sub-segmented into files and cement. On the basis of the end-user, the market is segmented into dental hospitals & clinics, dental institutes and dental academic and research institutes.
On a regional basis, the global dental industry market in the Americas is segmented into two major regions, i.e., North America and Latin America. The North American region is likely to hold the major share in the global dental industry market owing to the presence of well-established healthcare sector, growing prevalence of dental problems and also high disposable income. Additionally, the Asia-Pacific region is anticipated to be the fastest growing region due to the rising awareness about treatment and increasing healthcare facilities provides a favourable scenario for market growth.
Dental Industry Market Regional Analysis
The Americas dominate the global dental industry market owing to the increasing prevalence of fungal infection in the mouth, growing demand for cosmetic dentistry treatments and a huge patient population suffering from oral diseases across the Americas. According to the Centers for Disease Control and Prevention the US oral and dental health data 84.6% of children aged 2-17 years have a dental visit in the US in 2016 which increase the dental industry in this region.
Moreover, rising healthcare expenditure and the presence of developed economies like the US and Canada fuel the market growth.
Europe is second in the global dental industry market owing to a huge number of children’s suffering oral problems, increasing geriatric population, and presence of the developed economies like the UK, Italy, France, and others. Asia-Pacific region is the fastest growing market owing to the presence of developing economies, a growing healthcare sector and rising geriatric population drive the market with the region. The Middle East & Africa has the least share in the global dental industry market owing to the presence of poor economies and stringent government policies, especially in the African region.
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
TOC Continued….!
Browse Complete Report Details @
https://www.marketresearchfuture.com/reports/dental-industry-market-7637
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Healthcare Information Systems Market Industry Booming Demand by Top Regions and Major Segments Till 2023
The global healthcare information systems market is expected to grow at an approximate CAGR of 10.0% during forecast period, 2018–2023.
Health care information technology has shown to improve the quality of healthcare sector by enhancing disease surveillance, increased adherence to guidelines, and decreasing medication errors. The global health care information systems market has expanded rapidly over the years, and there has been a noticeable rise in adoption of health care information systems in recent times. Use of health care information systems in electronic prescriptions, medication management and intelligent wearable technologies to limit lifestyle diseases, and smart robots to systemize repetitive tasks is expected to significantly reduce health care costs and boost the market.
Global Healthcare Information Systems Market: Competitive Landscape
Some of the key players in the global healthcare information systems market are
Agfa-Gevaert N.V.
Allscripts Healthcare Solutions Inc.
Athenahealth Inc.
Carestream Health
Cerner Corporation
GE Healthcare
McKesson Corporation
Medidata Solutions Inc.
NextGen Healthcare
Philips Healthcare
Siemens Healthineers
Healthcare Information Systems Market Segmentation
The global healthcare information systems market is segmented based on type, components, deployment, end user, and region.
On the basis of type, the market is segmented into hospital information systems, pharmacy information systems, laboratory information systems, medical imaging information system, revenue cycle management. The hospital information systems segment is sub-segmented into electronic health record, electronic medical record, real-time healthcare, patient engagement solutions, population health management and others. The pharmacy information systems segment is sub-segmented into prescription management, automated dispensing systems, inventory management and others. The medical imaging information System is sub-segmented into radiology information systems, monitoring analysis software, picture archiving & communication systems and others. Based on components, the market is divided into two, i.e., Software and Hardware. Based on deployment, the market is divided into web-based, on premise and cloud-based. By end user, the market is divided into hospitals, diagnostics centre, academic and research institution, and others. On the basis of region, the market is segmented into the Americas, Europe, Asia Pacific and the Middle East & Africa.
Healthcare Information Systems Market Regional Analysis
The Americas leads the global healthcare information systems market. This can be attributed due to growing elderly population and presence of major market players within the region. Moreover, the presence of developed economies like U.S. and Canada within the region boost the market growth.
In 2017, followed by the Americas, Europe stood second in the global market owing to the presence of a well-developed healthcare infrastructure, increasing awareness and high healthcare expenditure. Asia Pacific was estimated to be the fastest growing region in 2017. This can be attributed due to the high contamination rate, increasing household income and growing penetration of the market players within the region. Moreover, rapidly growing pharmaceutical sector within the region boosts the market to grow. On the other hand, the Middle East and Africa held the least share in the global healthcare information systems market. This can be attributed due to the presence of poor economies, stringent government policies and low per capita income, especially within the African region. A majority of the of the market share within the Middle East & Africa is estimated to be held by the Middle East due to increasing government funding for healthcare, improving healthcare facilities and presence of developed economies like United Arab Emirates, Saudi Arabia, Kuwait, Dubai, and others.
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
TOC Continued….!
Browse Complete Report Details @
https://www.marketresearchfuture.com/reports/healthcare-information-systems-market-7325
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Global Orphan Drugs Market by Type and Size | Industry Report 2018-2023
Global Orphan Drugs Market - Synopsis
Orphan drugs are generally used for treating rare disorders and diseases that affect a small percentage of the population. There are approximately 30 million in Europe, 30 million people in the US, and 350 million people worldwide who suffer from 7,000 types of rare diseases.
Disorders among which four-fifths of the rare diseases are genetic and 50 % of the crowd affected being children. Only 5 % of the rare diseases had approved drug treatment with 326 new drugs being approved by FDA and brought to the market.
Competition Analysis:
The key players operating the orphan drugs market are
Alexion Pharmaceuticals Inc.
Bayer AG
Sanofi
Celgene Corporation
Novartis AG
Biogen Idec Limited
Hoffmann- La Roche
Takeda Pharmaceuticals Company Limited
Bristol-Myers Squibb
Vertex Pharmaceuticals Inc.
Johnson & Johnson
Segmentation Analysis:
Globally, the market for orphan drugs has been segmented on the basis of application, pharmacological class, source, technology, and region.
The market has been segmented into enzyme replacement, protein replacement, and gene chromosome expression based on pharmacological class.
The market has been segmented into oncology, blood-related disorders, neurology, nephrology, and infectious diseases based on applications. Among these, oncology is predicted to dominate the market owing to the increasing drug approvals for treating rare cancers.
The market has been segmented into Transgenic, DNA recombination, and gene expression based on technology.
The market has also been segmented into biological orphan drug and non-biological orphan drug based on source. Among these, biological orphan drug leads the market in terms of revenue and is predicted to maintain its dominance over the assessment period owing to the high efficacy of biologic products for treating diseases.
Future Drivers and Constraints Affecting the Market
Growing investment in R&D, unmet requirement for rare diseases, economic, legislative, and tax benefits offered by the government, high ROI, development of latest technologies like hybridoma, gene mapping, and DNA recombinant, extensive exclusivity, and faster uptake and low marketing cost are some of the major factors driving the market over the forecast period.
There has been a growing demand for drugs for rare diseases such as Yellow Fever, Von Willebrand Disease, Aarskog Syndrome, Waardenburg Syndrome, diabetic macular edema, Abetalipoproteinemia, Autism spectrum disorder (ASD), Yellow Nail syndrome, Asperger syndrome, Von Hippel-Lindau Disease, and others which is contributing towards the growth of the market. Moreover, FDA free waivers, R&D grants by the government, favorable reimbursement policy along with premium pricing owing to the low competition also contribute the market growth.
Meanwhile, high cost of development, extensive post-market surveillance, costly clinical trials, monopolized and unitary market, concern over safety, competition from biosimilars and generics are some of the restraining factors inhibiting the growth of the market over the forecast period. Moreover, active distribution and commercialization can be hindered by differential availability of developing and developed countries, owing to socio-economic factors.
Global Orphan Drugs Market - Industry News
The FDA has granted orphan drug designation to Surface Oncology's lead investigational candidate SRF231 which is a potential treatment for patients suffering from multiple myeloma. The SRF231 is a human monoclonal antibody therapeutic targeting CD47, a protein overexpressed on cancer cells to prevent them from being eliminated and engulfed by macrophage-mediated phagocytosis.
Browse Complete 84 Pages Premium Research Report Enabled with 121 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/orphan-drugs-market-2312
North America to Dominate the Market
Geographically, the market for orphan drugs has been spanned across regions such as North America, Europe, Asia Pacific, Middle East and Africa.
North America has been estimated to hold the largest market share owing to well-established healthcare infrastructure, favorable regulations for drug approval for rare diseases, initiatives by non-governmental and governmental agencies to increase awareness related to use of orphan drugs, and drug exclusivity status received by orphan drugs. Moreover, US contributes substantially to the market which calls for strong R&D for development of orphan drugs.
Table Of Contents
1. Report Prologue
2. Executive Summary
3. Market Introduction
3.1 Definition
3.2 Scope Of The Study
3.3 Assumptions & Limitations
3.3.1 Assumptions
3.3.2 Limitations
3.4 Market Structure
4. Research Methodology
4.1 Research Process
4.2 Primary Research
4.3 Secondary Research
4.4 Market Size Estimation
4.5 Forecast Model
TOC Continued…
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Opioids Market Prediction by 2023 – Worldwide Top Players Analysis, Demand and Trends in 2018
The global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017. Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications. According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.
The increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia, favorable reimbursement policies for palliative care in developed regions, and substantial rise in road accidents, trauma, and surgical procedures have led to the growth of the global opioids market in the recent years. However, rising addiction and death cases due to an overdose of opioid are likely to restrain market growth over the forecast period.
Global Opioids Market: Competitive Landscape
Some of the key players in the global Opioids Market are
Mallinckrodt (Surrey)
Vertice Pharma LLC (UK)
Janssen Global Services, LLC (US)
Egalet Corporation (US)
Sun Pharmaceutical Industries Ltd (India)
West-Ward Pharmaceuticals Corporation (Jordan)
Purdue Pharma L.P. (US)
Allergan Inc. (US)
Teva Pharmaceutical Industries Ltd (Israel)
Boehringer Ingelheim GmbH (Germany)
Sanofi SA (France), Pfizer Inc. (US)
Opioids Market Segmentation
The global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids. The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others. The extended-release opioid segment accounted for a value of USD 12,750.91 million in 2017. The immediate-release opioid segment is further segmented into codeine, hydrocodone, fentanyl, morphine, and others. The market, by application, can be segmented into pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction. On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.
Opioids Market Regional Analysis
The Americas is expected to hold the largest share of the global opioids market. This is owing to rising intravenous usage of opioids in the region. Also, high awareness among people regarding the medical uses of opioids is expected to drive the market growth in the region.
Europe showed a considerable amount of growth in the market due to increasing palliative care facilities and reformed regulations for the prescription of opioids. Asia-Pacific is estimated to be the fastest growing region in the global market. Populace demographics and increased availability of effective opioid medications are likely to be the key factors for the growth of Asia-Pacific opioids market during the forecast period. South Korea held a share of 6% in the Asia-Pacific opioids market in 2017. Also, the Middle East and Africa region is expected to steadily grow owing to the rising number of opioid manufacturers in the North African region.
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.4.3 Market Structure
3. Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Size Estimation
3.4 Forecast Model
4. Market Dynamics
TOC Continued….!
Browse Complete Report Details @
https://www.marketresearchfuture.com/reports/opioids-market-7626
About US:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Healthcare Predictive Analytics Market Regional Data Analysis by Production, Revenue, Price and Gross Margin
It Is Estimated That the Global Healthcare Predictive Analytics Market Is Expected To Register A CAGR ~29.3% During the Forecast Period Of 2018–2023.
The global healthcare predictive analytics market is expected to witness tremendous growth owing to the government initiatives to increase EHR adoption, growing venture capital investments, growing pressure to curb healthcare spending and improve patient outcomes. Other key factors such as rising healthcare costs; curb fraudulent claims, optimize provider networks, operational costs; increasing competition, the growing need to increase memberships are compelling healthcare payers to adopt analytics solutions.
However, factors such as lack of trained medical professionals is expected to curb the growth of the market during the forecast period.
On the regional basis, the healthcare predictive analytics market in the Americas is predicted to dominate the market during the forecast period. The North American region holds substantial share in the global market.
This owes to the growth of federal healthcare regulations that curb the rising healthcare costs; rising government initiatives focusing on personalized medicine, growing EHR adoption; and population health management.
Currently, the global healthcare predictive analytics market is dominated by numerous players. The major players in this market are involved in new product launches, strategic partnerships and collaborations to increase their product portfolio. For example, in August 2018, Verscend Technology acquired Cotiviti Holdings, Inc., a leading provider of payment accuracy and analytics-driven solutions focused primarily on the healthcare industry. Also, in July 2018, Health Catalyst acquired Medicity, a PHM company offering solutions for HIEs, business intelligence, and provider and patient engagement.
Key Players
Some Of The Key Players In The Global Intraocular Lens Market Are IBM Corporation (US), Optum, Inc. (US), Cerner Corporation (US), SAS Institute, Inc. (US), Allscripts Health Solutions (US), McKesson Corporation (US), MedeAnalytics, Inc. (US), Inovalon (US), Oracle Corporation (US), Health Catalyst (US), SCIO Health Analytics (US), Verscend Technologies, Inc. (US), CitiusTech, Inc. (US), Wipro Limited (India), and VitreosHealth (US).
Segmentation
The global healthcare predictive analytics market is segmented on the basis of component, application, and end user.
For instance, IBM invests a significant amount of its revenue in research activities to continuously improve its product portfolio. The company has invested nearly USD 24 billion in the development of its big data and analytics software and services. The major steps undertaken by the company was the acquisition of Truven Health Analytics in April 2016. This acquisition had assisted the company to acquire a major share of the global market.
Regional Analysis
On the regional basis, the healthcare predictive analytics market in the Americas is predicted to dominate the market during the forecast period. The North American region holds substantial share in the global market.
This owes to the growth of federal healthcare regulations that curb the rising healthcare costs; rising government initiatives focusing on personalized medicine, growing EHR adoption; and population health management.
Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/healthcare-predictive-analytics-market-7549
Table Of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Overview
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
TOC Continued….
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]
0 notes
Text
Dental Biomaterials Market by Technology & End-User - 2023 | Market Research Future
Dental biomaterials are fabricated/natural structures used in dentistry. The rising prevalence of dental caries and increasing incidences of dental trauma produces developmental backgrounds for the global dental biomaterials market. Moreover, factors such as increasing dental expenditure, growing dental tourism, and rising investments boost market growth. Developing countries like India are becoming a global spot for dental tourists. This can be attributed due to the cheap and quality dental services provided within the country.
A study published by the Journal of Clinical and Diagnostic Research in 2016, stated that in India a typical dental implant costs about USD 600 in comparison to USD 2,000 and 1070 for US and Hungary, respectively. Such trends are estimated to grow the market by utilizing the potential of the Asia-Pacific region. However, factors such as high cost of implants followed by reported cases of peri-implantitis and peri-implant mucositis restraints the market growth.
The Global Dental Biomaterials Market is expected to register an approximate CAGR of 6.2% during the forecast period, 2018–2023.
Segmentation
The global dental biomaterials market is segmented on the basis of type, application, and end user.
Based on type, the market is segmented into metallic biomaterials, ceramic biomaterials, polymeric biomaterials, metal-ceramic biomaterials, natural biomaterials. The metallic biomaterials segment is further divided into titanium, stainless steel, and chromium alloys, and others.
The application segment is sub-segmented into implantology, prosthodontics, orthodontics, others.
The end user segment is divided into dental product manufacturers, dental laboratories, dental hospitals and clinics, dental academies, and research institutes.
Key Players
Some of the key players in the global dental biomaterials market are
Straumann Holding AG
Geistlich Pharma AG
Zimmer Biomet Holdings, Inc.
Danaher Corporation
Dentsply Sirona, Inc.
3M Company
Royal DSM
Carpenter Technology Corporation
Kuraray Co., Ltd
Medtronic PLC
Henry Schein, Inc.
Mitsui Chemicals, Inc.
Victrex PLC
Ivoclar Vivadent AG
GC Corporation
Keystone Dental, Inc.
Datum Dental Ltd
Bego Medical GmbH
Cam Bioceramics B.V.
Regional Analysis
The Americas dominates the global market for dental biomaterials. Factors such as the rising prevalence of caries, high dental expenditure, and the presence of major players within the region boost the market. On a regional basis, the Americas is segmented into North America and South America. The North American region is estimated to lead the market owing to the developed economies like the US, Canada, and others within the region.
Following similar trends, Europe stood second in the market. Well-developed dental sector and increasing dental patient pool are estimated to drive the regional market of Europe. In 2017, Asia-Pacific was estimated to be the fastest growing region due to increasing awareness for oral health and rapidly growing dental industries. On the other hand, the Middle East and Africa is estimated to occupy the least share in the global dental biomaterials market. Presence of poor economies, lack of awareness, stringent government policies, and low healthcare expenditure restraints the market within the region.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]
0 notes
Text
Anticholinergic Drugs Market Revenue at CAGR of ~4.50% Forecasts by 2024
The Global Anticholinergic Drugs Market is expected to register a CAGR of 4.50% during the forecast period with a market value of USD 7,149.90 million till 2024. Anticholinergics drugs are a broad class of drugs that block acetylcholine-mediated neurotransmission in the smooth muscle, heart, central, and peripheral nervous systems. Acetylcholine is a neurotransmitter, or a chemical messenger released by nerve cells to send signals to other cells.
The increasing prevalence of chronic diseases and increasing investments and funding in the field of life science research has led to the growth of the global anticholinergic drugs market in recent years. Moreover, the aging population is expected to fuel market growth. However, side-effects of anticholinergic drugs and stringent regulations are projected to hamper the growth of the market during the assessment period.
Global Anticholinergic Drugs Market: Competitive Landscape
Some of the key players in the global Anticholinergic Drugs Market are
Pfizer Inc. (US)
Allergan Plc (US)
Astellas Pharma Inc. (Japan)
Johnson & Johnson Services Inc. (US)
Teva Pharmaceutical Industries Ltd (Israel)
Sanofi (France)
GlaxoSmithKline Plc (UK)
Boehringer Ingelheim International GmbH (Germany)
Anticholinergic Drugs Market Segmentation
The anticholinergic drugs market, based on product type, has been segmented into synthetic compounds, natural, semi-synthetic compounds. The anticholinergic drugs market, based on application, has been segmented into the overactive bladder, Parkinson’s disease, chronic obstructive pulmonary disease, muscle spasms, irritable bowel syndrome. On the basis of route of administration, the market is segmented into oral, parenteral, topical. On the basis of end user, the market is segmented into hospitals and pharmacies.
Anticholinergic Drugs Market Regional Analysis
The Global Anticholinergic Drugs Market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is expected to hold the largest share of the global anticholinergic drugs market. This owes to the rising geriatric population along with the high prevalence of CNS diseases and demand for effective therapies. The Europe market demonstrated substantial growth in the market due to the rising prevalence of bladder overactivity, increasing geriatric population, and rising healthcare expenditure. Germany held a share of 25.8% in the Western Europe anticholinergic drugs market in 2018. Asia-Pacific is estimated to be the fastest growing region in the global market due to the presence of a large number of research organizations and development of new infrastructure to support the healthcare industry. Also, the Middle East and Africa region is expected to show the least growth owing to low per capita income and lack of adequate healthcare spending.
Table Of Content
1. Market Introduction
1.1 Definition
1.2 Scope Of The Study
1.3 List Of Assumptions
1.4 Market Structure
2. Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
2.4 Market Size Estimation
2.5 Forecast Model
3. Market Dynamics
3.1 Introduction
3.2 Drivers
3.2.1 Rising Geriatric Population
3.2.2 Increasing Prevalence Of Chronic Diseases
3.2.3 Increasing Investments And Funding In The Field Of Life Science Research
3.3 Restraints
3.3.1 Side-Effects Of Anticholinergic Drugs
3.3.2 Stringent Regulations
3.4 Opportunity
3.4.1 Entering Developing Economies
TOC Continued….!
Browse Complete Report Details @
https://www.marketresearchfuture.com/reports/anticholinergic-drugs-market-7895
About US:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Healthcare Consulting Services Market Research, Global Analysis, Industry Demand and Forecast 2024
The Global Healthcare Consulting Services Market is expected to register a CAGR of 10.4% during the forecast period of 2019 to 2024.
Healthcare consulting services is an essential tool which are used in various healthcare centers. These services help in patient management in hospitals, product launching in healthcare industry and used in data management. It also, helps to maintain connection between the patient and healthcare staff.
There is a high demand of healthcare consulting services in hospitals, clinics, healthcare companies, and other healthcare facilities. The key factors contributing for the market growth are growing awareness about the patient safety, rising demand for best practices in hospitals and healthcare centers, and rising government regulation regarding patient safety boosts the market growth.
However, the problem such as high cost for software development and complication in using it hinders the market growth.
Global Healthcare Consulting Services Market: Competitive Landscape
Some of the key players in the global Healthcare Consulting Services Market are
Accenture Consulting (US)
McKinsey and Company (US)
Cognizant (US)
Deloitte Consulting (US)
Ernst and Young (UK)
Bain and Company (US)
Deloitte Touche Tohmatsu Limited (US)
Huron Consulting (US)
KPMG (Switzerland)
PWC (UK)
The Boston Consulting Group (US)
Healthcare Consulting Services Market Segmentation
The global healthcare consulting services market is segmented on the basis of type of service, component, application, and end user.
On the basis of the type of service, the global healthcare consulting services market is categorized into IT consulting, digital consulting, financial consulting, operations consulting, and strategy consulting.
On the basis of the component, the global healthcare consulting services market is segmented into services, software, and hardware. On the basis of application, the market is segmented into operations management, financial, population health, and clinical. On the basis of operations management, the market is sub-segmented into demand forecasting, workforce planning and scheduling, inpatient scheduling, and outpatient scheduling. Based on population health the market is sub-segmented into
population risk management, patient engagement, population therapy management, and others. On the basis of finance, the market is sub-segmented into revenue cycle management, fraud detection, and others. Based on clinical the market is sub-segmented into quality benchmarking, patient care enhancement, and clinical outcome analysis and management.
On the basis of the end user, the market is segmented into hospitals and clinics, life science companies, and government bodies.
Healthcare Consulting Services Market Regional Analysis
The Americas dominate the global healthcare consulting services market due to the presence of a large number of healthcare companies and increasing competition in the healthcare industry. To compete and lead the market the healthcare companies prefer consulting service provider for new strategies and solutions. American Healthcare Consulting, LLC is one of the healthcare consulting firms focuses on patient care, helps hospitals in managing their billing process, procurement of products and other activities.
The global healthcare consulting services market in Europe is the second largest. Factors such as rising government support for the healthcare sector, huge patient population and an increasing number of hospitals in this region support the market growth. Also, the rising adoption of software related to life sciences by key companies helps in increase of the demand for healthcare consulting services in this region.
Asia-Pacific region is the fastest growing market owing to the presence of developing economies like India, China, and Australia. Moreover, the rising initiatives taken by public and private organizations fuel the growth of the healthcare consulting services in major countries in Asia-Pacific region.
On the other hand, the Middle East & Africa has the least share in the global healthcare consulting services market. This can be attributed to the presence of poor economies, low awareness and lack of healthcare infrastructure affect the market growth.
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Technology Trends & Assessment
TOC Continued….!
Browse Complete Report Details @
https://www.marketresearchfuture.com/reports/healthcare-consulting-services-market-7860
About US:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Hepatitis B Treatment Market Industry Booming Demand by Top Regions and Major Segments Till 2024
The global Hepatitis B Treatment Market is expected to grow at an approximate CAGR of 5.3% during the forecast period, 2018–2024.
Hepatitis B is a viral infection caused by a hepatitis B virus. This infection lasts for a longer period and can cause many other complications, such as scarring in the liver, liver cancer or liver failure. The person suffering from hepatitis B faces various symptoms such as fever, fatigue, nausea, and muscle aches. The other symptoms include jaundice, swelling in the legs, poor appetite, drowsiness and many more. The key factors contributing the market growth are growing geriatric population, increasing the prevalence of viral infection and growing sexually transmitted diseases among the population contribute to driving the market growth. The World Hepatitis Alliance (WHA), 2017 reported that 52 million children across the world are living with viral hepatitis. Such a huge population suffering from Hepatitis boosts the market growth.
However, the factor such as the side effects or complication caused due to treatment may hamper the market growth.
Global Hepatitis B Treatment Market: Competitive Landscape
Some of the key players in the global Hepatitis B Treatment Market are
Accord Healthcare Inc.
Apotex Corp.
Arbutus Biopharma
Arrowhead Pharma
Aurobindo Pharma Limited
Bristol-Myers Squibb Company
Gilead Sciences, Inc.
GlaxoSmithKline
Lupin Pharmaceuticals, Inc.
Merck & Co., Inc.
Par Pharmaceutical, Inc.
Teva Pharmaceuticals
Zydus Pharmaceuticals
Hepatitis B Treatment Market Segmentation
The global Hepatitis B Treatment Market is segmented on the basis of type, treatment, distribution channel, and region.
Based on type, the market is segmented into acute and chronic. On the basis of treatment, the global Hepatitis B Treatment Market is segmented into immune modulator drugs, antiviral drugs, vaccine, and surgery (liver transplant). The immune modulator drugs are further sub-segmented into pegylated interferon and interferon alpha. The antiviral drugs are sub-segmented into tenofovir disoproxil, entecavir, telbivudine, lamivudine, and others. By distribution channel, the market is segmented into hospital & retail pharmacies and online pharmacies.
Hepatitis B Treatment Market Regional Analysis
The Americas dominates the global market for Hepatitis B Treatment Market. Factors such as the presence of a large number of healthcare companies, increasing geriatric population and high healthcare expenditure among the population within the Americas drives the market. The National Vaccine Information Center reported 3,370 cases of hepatitis B were reported in the US in 2015.
Following similar trends, Europe stood second in the global Hepatitis B Treatment Market market. The increased prevalence of viral diseases and growing healthcare expenditure in this region boost market growth. Also, the presence of developed economies, increasing healthcare facilities, and rising government funding for healthcare boost market growth. Asia Pacific was the fastest growing region for the global Hepatitis B Treatment Marketin 2017. This can be attributed due to the increasing incidences of HIV infection and rising demand for the treatment of viral infection among the population boosts market growth.
On the other hand, the Middle East and Africa holds the least share in the global Hepatitis B Treatment Market market. The poor economies within the African region and lack of awareness about the treatment methods hinder the market growth.
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Treatment Trends & Assessment
TOC Continued….!
Browse Complete Report Details @
https://www.marketresearchfuture.com/reports/hepatitis-b-treatment-market-7817
About US:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Global Opioids Market by Type and Size | Industry Report 2018-2023
The global opioids market is expected to register a CAGR of 7.12% during the forecast period with a market value of USD 19,554.49 million in 2017. Opioids are a type of narcotic pain medications that are used to treat moderate to severe pain medications. According to the National Health Interview Survey 2017, 25.3 million Americans suffer from chronic pain daily and 23.4 million people reported their pain as severe.
The increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia, favorable reimbursement policies for palliative care in developed regions, and substantial rise in road accidents, trauma, and surgical procedures have led to the growth of the global opioids market in the recent years. However, rising addiction and death cases due to an overdose of opioid are likely to restrain market growth over the forecast period.
Global Opioids Market: Competitive Landscape
Some of the key players in the global Opioids Market are
Mallinckrodt (Surrey)
Vertice Pharma LLC (UK)
Janssen Global Services, LLC (US)
Egalet Corporation (US)
Sun Pharmaceutical Industries Ltd (India)
West-Ward Pharmaceuticals Corporation (Jordan)
Purdue Pharma L.P. (US)
Allergan Inc. (US)
Teva Pharmaceutical Industries Ltd (Israel)
Boehringer Ingelheim GmbH (Germany)
Sanofi SA (France), Pfizer Inc. (US)
Opioids Market Segmentation
The global opioids market, by product, has been segmented into extended-release/long-acting opioids and immediate-release/short-acting opioids. The extended-release opioid segment is further segmented into oxycodone, oxymorphone, morphine, hydromorphone, and others. The extended-release opioid segment accounted for a value of USD 12,750.91 million in 2017. The immediate-release opioid segment is further segmented into codeine, hydrocodone, fentanyl, morphine, and others. The market, by application, can be segmented into pain relief, anesthesia, cough suppression, diarrhea suppression, and de-addiction. On the basis of end user, the global opioids market is segmented into hospitals & clinics, pharmacies, and academic research institutes.
Opioids Market Regional Analysis
The Americas is expected to hold the largest share of the global opioids market. This is owing to rising intravenous usage of opioids in the region. Also, high awareness among people regarding the medical uses of opioids is expected to drive the market growth in the region.
Europe showed a considerable amount of growth in the market due to increasing palliative care facilities and reformed regulations for the prescription of opioids. Asia-Pacific is estimated to be the fastest growing region in the global market. Populace demographics and increased availability of effective opioid medications are likely to be the key factors for the growth of Asia-Pacific opioids market during the forecast period. South Korea held a share of 6% in the Asia-Pacific opioids market in 2017. Also, the Middle East and Africa region is expected to steadily grow owing to the rising number of opioid manufacturers in the North African region.
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.4.3 Market Structure
3. Research Methodology
3.1 Primary Research Methodology
3.2 Secondary Research Methodology
3.3 Market Size Estimation
3.4 Forecast Model
4. Market Dynamics
TOC Continued….!
Browse Complete Report Details @
https://www.marketresearchfuture.com/reports/opioids-market-7626
About US:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes
Text
Medical Marijuana Market Opportunities, Drivers, Top Players, Analysis and Forecasts Till 2023
The Global Medical Marijuana Market is expected to register a CAGR of 34.0% to reach USD 54,677.1 Million by 2023.
Marijuana is a plant having some chemical compound “cannabis” that has medical property. This plant is used as a raw material by various pharmaceutical companies to manufacture drugs for various therapeutic applications. Marijuana plants extracts are used to treat the disease and various conditions caused by the disease such as the central nervous system, cancer, Alzheimer’s and used in anti-aging products.
The rising prevalence of chronic diseases, growing therapeutic applications of the marijuana plant, growing acceptance of marijuana for medical treatment in many countries, and increasing the authorization of marijuana are anticipated to drive the market growth.
The American accounts the largest market share in 2017. Followed by America, Europe holds the second position and represents 5.5%of the entire market. Europe holds the second position owing to the increasing demand of marijuana for the treatment of neural problems and various chronic diseases. In Europe, West Europe holds the largest share. Whereas the Asia-Pacific is expected to register the fastest CAGR.
Global Medical Marijuana Market: Competitive Landscape
Some of the key players in the global Medical Marijuana Market are
Canopy Growth Corporation (US)
Cannabis Sativa Inc (Nevada)
GW Pharmaceuticals Plc (US)
Emerald Health Therapeutics Inc. (Victoria, BC)
Tilray (Nanaimo, BC)
Aphria (Ontario)
CanniMed Ltd (Canada)
Cara Therapeutics (US)
Pfizer Inc. (US)
Medical Marijuana Inc(US)
GBSciences Inc.( Nevada)
MediPharm Labs(US)
Medical Marijuana Market Segmentation
The global medical marijuana market is segmented into product type, application, and distribution channel. On the basis of product type, the market is segmented into solids, dissolvable/powders, oil, and ointments & creams. The dissolvable/powders segment is expected to lead the market and register a substantial CAGR to reach USD 22,648.8 million by the end of 2023. Due to the affordability and convenience in using drives, the demand for this segment. The global medical marijuana market by application is segmented into Alzheimer’s disease, cancer, schizophrenia, and multiple sclerosis. On the basis of distribution channel, the market is segmented into retail & pharmacy stores, online platforms, and others.
Medical Marijuana Market Regional Analysis
Geographically, the global medical marijuana market has been segmented into North America, Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis, the Americas was the largest market for medical marijuana in 2017 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. Major factors influencing the growth of the market increasing demand for marijuana-based medicines for the treatment of chronic diseases such as Alzheimer, Cancer, and respiratory problems. The Asia-Pacific medical marijuana market is one of the fastest growing regions across the globe.
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Scope Of Study
2.2 Research Objective
2.3 List Of Assumptions
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
TOC Continued….!
Browse Complete Report Details @
https://www.marketresearchfuture.com/reports/medical-marijuana-market-6470
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]
0 notes